Electroacupuncture for Alzheimer's Disease: A 24-Week Randomized Controlled Trial

A randomized controlled trial from China investigating the long-term efficacy of electroacupuncture for Alzheimer's disease. Sixty-six patients were allocated to treatment or sham groups for a 24-week period with a 4-week follow-up. The dataset includes primary outcomes from the Alzheimer's Disease Assessment Scale–Cognitive (ADAS-Cog) and secondary measures of daily living and behavioral symptoms.

Use Cases

• Analyze the time-dependent relationship of electroacupuncture treatment on cognitive scores based on the 24-week intervention and 4-week follow-up periods mentioned.
• Compare treatment efficacy between electroacupuncture and sham groups based on the randomized controlled trial design described.
• Investigate secondary outcomes for Alzheimer's patients based on the assessment of activities of daily living and behavioral symptoms mentioned in the results.

Strengths

• The dataset is associated with a registered clinical trial (ChiCTR2200056329), providing a traceable research context.
• The study design includes a 24-week treatment period and a 4-week follow-up, allowing for analysis of sustained effects.

Limitations

• The dataset is a 402.6 KB DOCX file; its internal structure, column definitions, and row count are unknown.
• The description does not specify geographic details beyond the Chinese clinical trial registry, limiting assessment of population representativeness.

Provenance

Source

Ran Li via figshare.

Collection Method

Data collected from a randomized controlled clinical trial.

Time Range

Covers a 24-week treatment period plus a 4-week follow-up.

Freshness

Last updated 2026-05-04 05:32:18; freshness should be verified.

Geography

Likely China, based on the clinical trial registry domain (.cn).